echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Cell Death Dis: New discovery of pathogenesis of radioactive optic neuropathy.

    Cell Death Dis: New discovery of pathogenesis of radioactive optic neuropathy.

    • Last Update: 2020-09-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Radiotherapy (RT) is one of the main treatments for head, neck and/or skull-related tumors.
    this method is currently common, there are serious complications.
    , radioactive optic neuropathy (RION) is a serious late-oncward complication caused by radiation therapy (EBRT).
    RION may occur on one or both sides and cause acute or irreversible vision impairment and vision loss.
    because the detailed pathogenesis of RION is not yet known, an in-depth study of RION pathogenesis will help to develop effective interventions and improve the quality of life of radiotherapy patients.
    study found that radiotherapy causes changes in mitochondrial dynamics by regulating mitochondrial division-related proteins Drp1 and Fis1, while producing too much reactive oxygen (ROS), which eventually leads to neuron damage and visual impairment.
    In addition, the researchers found that an important mechanism in the rion process, Cdk5 (cell cycle protein-dependent kinase 5), was able to regulate mitochondrial dynamics defects associated with neuron damage by mediated phosphatization of Drp1's 616th bit of ser616.
    the use of Cdk5 inhibitors roscovitine and Drp1 inhibitors mdivi-1 in pharmacology can inhibit mitochondrial division and the production of ROS associated with radioactive neuron damage.
    , the above findings are of great clinical significance in preventing RION.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.